SNX15 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.22044604925031E-16 |
Normal-vs-Stage2 |
9.5532999999981E-05 |
Normal-vs-Stage3 |
4.78130000003407E-06 |
Normal-vs-Stage4 |
4.37020000000343E-05 |
Stage1-vs-Stage2 |
9.788600E-01 |
Stage1-vs-Stage3 |
8.123000E-01 |
Stage1-vs-Stage4 |
4.301200E-01 |
Stage2-vs-Stage3 |
8.867600E-01 |
Stage2-vs-Stage4 |
4.821000E-01 |
Stage3-vs-Stage4 |
5.858600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.62447832963153E-12 |
Normal-vs-AfricanAmerican |
2.67752486848849E-12 |
Normal-vs-Asian |
1.079640E-01 |
Caucasian-vs-AfricanAmerican |
8.361400E-01 |
Caucasian-vs-Asian |
8.829800E-01 |
AfricanAmerican-vs-Asian |
9.340600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.62447832963153E-12 |
Normal-vs-Female |
1.43959999476806E-09 |
Male-vs-Female |
2.020600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.02650110633817E-11 |
Normal-vs-Extreme_Weight |
6.66133814775094E-16 |
Normal-vs-Obese |
7.32349958454392E-10 |
Normal-vs-Extreme_Obese |
1.944060E-03 |
Normal_Weight-vs-Extreme_Weight |
8.038600E-01 |
Normal_Weight-vs-Obese |
2.231000E-01 |
Normal_Weight-vs-Extreme_Obese |
7.755000E-01 |
Extreme_Weight-vs-Obese |
2.507400E-01 |
Extreme_Weight-vs-Extreme_Obese |
8.868600E-01 |
Obese-vs-Extreme_Obese |
6.630600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
6.694200E-02 |
Normal-vs-Age(41-60Yrs) |
4.02677891031544E-13 |
Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
Normal-vs-Age(81-100Yrs) |
9.68230000000236E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.105700E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.240400E-03 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.825750E-02 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.399600E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.778750E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.591800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.73072667308816E-12 |
Normal-VS-Type2 PRCC |
1.62436730732907E-12 |
Normal-VS-KIRP CIMP |
4.360500E-03 |
Normal-VS-Unclassified PRCC |
2.44010000000072E-05 |
Type1 PRCC-VS-Type2 PRCC |
1.79229999999198E-05 |
Type1 PRCC-VS-KIRP CIMP |
2.404600E-01 |
Type1 PRCC-VS-Unclassified PRCC |
7.286800E-01 |
Type2 PRCC-VS-KIRP CIMP |
1.381110E-03 |
Type2 PRCC-VS-Unclassified PRCC |
6.559600E-04 |
KIRP CIMP-VS-Unclassified PRCC |
3.390600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.7907999527722E-09 |
Normal-vs-N1 |
2.36120000000062E-05 |
Normal-vs-N2 |
1.416360E-02 |
N0-vs-N1 |
7.494400E-01 |
N0-vs-N2 |
6.778400E-02 |
N1-vs-N2 |
4.236500E-02 |
|
|